30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States

Janssen Oncology Inc (NONE)

Track

Stock chart
Ticker: NONE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
ROSENWALD LINDSAY A MD
1 sale — total 429,000 USD
Sale 9 Jun 2009
Value US$3,895,705.12 | Price 46.14 | Shares 80,524
Buy 21 Feb 2008
Value US$947,290.32 | Price 477.19 | Shares 83,646
Buy 21 Feb 2008
Value US$4,226,599.58 | Price 416.82 | Shares 439
Buy 18 Dec 2007
Value US$457,500.00 | Price 30.50 | Shares 15,000
Buy 19 Jul 2007
Value US$175,479.00 | Price 21.75 | Shares 8,068
Buy 18 Jul 2007
Value US$184,875.00 | Price 21.75 | Shares 8,500
Buy 17 Jul 2007
Value US$72,862.50 | Price 21.75 | Shares 3,350
Buy 18 Jun 2007
Value US$88,430.00 | Price 23.90 | Shares 3,700
Buy 8 May 2007
Value US$149,810.00 | Price 21.10 | Shares 7,100
Buy 27 Feb 2007
Value US$18,550.00 | Price 18.55 | Shares 1,000
Buy 26 Feb 2007
Value US$9,425.00 | Price 18.85 | Shares 500
Buy 26 Feb 2007
Value US$101,200.00 | Price 18.40 | Shares 5,500
Buy 26 Feb 2007
Value US$73,200.00 | Price 18.30 | Shares 4,000
Buy 26 Feb 2007
Value US$72,600.00 | Price 18.15 | Shares 4,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2009-06-10 2009-06-09 S Sale ROSENWALD LINDSAY A MD Large shareholder
80,524 -13.4%
46.14
US$3,895,705 		80,524 -13.4% 46.14 US$3,895,705
2008-03-03 2008-02-21 B Purchase Belldegrun Arie Non-Executive Director
83,646 -27.6%
477.19
US$947,290 		83,646 -27.6% 477.19 US$947,290
2008-03-03 2008-02-21 B Purchase Belldegrun Arie Non-Executive Director
439 -20.9%
416.82
US$4,226,600 		439 -20.9% 416.82 US$4,226,600
2007-12-20 2007-12-18 B Purchase Belldegrun Arie Non-Executive Director
15,000 +33.6%
30.50
US$457,500 		15,000 +33.6% 30.50 US$457,500
2007-07-20 2007-07-19 B Purchase Malley Thomas Non-Executive Director
8,068 +68.1%
21.75
US$175,479 		8,068 +68.1% 21.75 US$175,479
2007-07-20 2007-07-18 B Purchase Malley Thomas Non-Executive Director
8,500 +253.7%
21.75
US$184,875 		8,500 +253.7% 21.75 US$184,875
2007-07-20 2007-07-17 B Purchase Malley Thomas Non-Executive Director
3,350 +inf%
21.75
US$72,862 		3,350 +inf% 21.75 US$72,862
2007-06-19 2007-06-18 B Purchase Belldegrun Arie Non-Executive Director
3,700 +9.0%
23.90
US$88,430 		3,700 +9.0% 23.90 US$88,430
2007-05-10 2007-05-08 B Purchase Belldegrun Arie Non-Executive Director
7,100 +21.0%
21.10
US$149,810 		7,100 +21.0% 21.10 US$149,810
2007-03-09 2007-02-27 B Purchase Belldegrun Arie Non-Executive Director
1,000 +3.0%
18.55
US$18,550 		1,000 +3.0% 18.55 US$18,550
2007-03-09 2007-02-26 B Purchase Belldegrun Arie Non-Executive Director
500 +1.5%
18.85
US$9,425 		500 +1.5% 18.85 US$9,425
2007-03-09 2007-02-26 B Purchase Belldegrun Arie Non-Executive Director
5,500 +20.5%
18.40
US$101,200 		5,500 +20.5% 18.40 US$101,200
2007-03-09 2007-02-26 B Purchase Belldegrun Arie Non-Executive Director
4,000 +17.5%
18.30
US$73,200 		4,000 +17.5% 18.30 US$73,200
2007-03-09 2007-02-26 B Purchase Belldegrun Arie Non-Executive Director
4,000 +21.2%
18.15
US$72,600 		4,000 +21.2% 18.15 US$72,600
Explore more

More insider trading research around Janssen Oncology Inc

More insider trades in United States
Insider trading in North America